For the second consecutive year, Reshma Kewalramani, CEO and President of Vertex Pharmaceuticals, has been named on the Stat Status List as a changemaker in Health and Medicine.
Dr. Reshma Kewalramani, M.D., CEO and President of Vertex Pharmaceuticals, along with other life science industry leaders, joined Boston Mayor Michelle Wu at the announcement of $4.7 million funding for the training and placement of Boston residents as part of the City of Boston's Life Sciences Workforce Initiative.